CLEXIO
LIVE

Serial Number

79245805

Owner

Clexio Biosciences Ltd.

Attorney

Sarah Anne Keefe

Filing Date

May 23, 2018

Add to watchlist:

No watchlists yet
View on USPTO

CLEXIO Trademark

Serial Number: 79245805 • Registration: 5772284

CLEXIO is a trademark filed by Clexio Biosciences Ltd. on May 23, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Clexio Biosciences Ltd. (4 trademarks)

21 Nahum Haftzadi Street,

Entity Type: 03

Trademark Details

Filing Date

May 23, 2018

Registration Date

June 11, 2019

Published for Opposition

March 26, 2019

Goods & Services

[ Surgical apparatus and ] instruments for medical [ , dental or veterinary ] use; medical [ , surgical, dental and veterinary ] apparatus and instruments, namely, [ medical fluid injectors for the delivery of pharmaceuticals; medical devices, namely, devices for reconstituting dried pharmaceuticals; medical apparatus and instruments, namely, medical infusion set for ] subcutaneous delivery of pharmaceuticals; medical apparatus for the preparation and parenteral infusion of pharmaceutical preparations; [ medical apparatus and instruments for use in transplantation; ] medications dispensing apparatus and instruments, namely, medical apparatus and units for dosage, measuring, monitoring and delivery of drugs [ ; artificial limbs, eyes and teeth; orthopedic articles, namely, orthopedic braces, joint implants, namely, orthopedic joint implants made of artificial materials, orthopedic shoe inserts, wrist, neck, back, ankle, knee and elbow supports for therapeutic purposes, splints; joint prostheses; bone prostheses; surgical implants comprised of artificial materials; medical implants made of artificial materials; suture materials; massage apparatus; sexual activity apparatus, namely, sex toys ]

[ Retail and wholesale services, namely, retail store and wholesale store services featuring pharmaceutical preparations, medicines, medical, surgical and dental apparatus and instruments, nutritional supplements, vitamins and mineral supplements; business management services, namely, business management consulting and advisory services; providing office functions; import agencies, namely, import agency services in the field of pharmaceutical and medical products; sales promotion services; business information services; public relations; ] electronic commerce services, namely, providing information about products via telecommunication networks for advertising and sales purposes; [ purchase of advertising space in the nature of advertising services, namely, consulting in the field of marketing to ensure clients purchase advertising in the most effective time slots; rental of advertising space; direct mail advertising services; business networking; arranging of business introductions, namely, business networking; advertising, marketing and promotional services for the pharmaceuticals and medical products of others; providing marketing and promotional services of pharmaceutical preparations and medical products of others; market research services relating to pharmaceuticals and medical products; conducting business surveys and the collection of data, namely, analyzing and compiling business data relating to pharmaceuticals, medical products and medical activities; ] commercial information and consumer advice relating to pharmaceuticals, medical products and medical information [ ; organization of trade, namely, organization of trade fairs for commercial or advertising purposes relating to pharmaceuticals and medical products; distribution of samples for publicity purposes; providing price comparison services and procurement services, namely, procurement of pharmaceuticals and medical products for others ]

Organization of business conferences, namely, educational business seminars in the field of pharmaceuticals and medical products; organization of conventions, namely, organizing conventions for educational purposes relating to pharmaceuticals and medical products

Pharmaceutical and medical preparations for the treatment of [ genetic, cardiovascular, ] central nervous system, endocrine, [ gastrointestinal, hepatic, biliary, ] immunological, allergic, [ pulmonary, ] dermatological, infectious, inflammatory, [ menopausal, nutritional, metabolic, diabetes, autoimmune, musculoskeletal, connective tissue, ] neurological, [ ophthalmologic, ] psychiatric, [ respiratory, urogenital, urological, erectile dysfunction, sexual dysfunction, gynecology, obstetric, pediatric, hematologic, oncological, fungal and viral diseases and disorders; Pharmaceutical preparations for the relief of pain, anesthesia and reducing fever; Pharmaceutical, medicinal vegetal, medicinal herbal and natural remedy preparations and substances for the treatment of anxiety and depression; vitamins; mineral supplements; food supplements; nutritional supplements; dietetic substances, namely, dietetic foods adapted for medical purposes; Medicated plants, roots and herbs, all of the foregoing being plant, root, and herb extracts for medical, veterinary and pharmaceutical purposes; plant extracts sold as components of nutritional supplements for medical use; medical beverages, namely, dietetic beverages adapted for medical purposes; medical tea, namely, herbal teas for medicinal purposes; sanitary preparations for medical purposes; food for babies; dietary supplements for humans and animals; medical plasters, materials for dressings, namely, gauze for dressings, medical adhesive tape, namely, dissolvable strips to stop bleeding from minor cuts; materials for stopping teeth, dental wax; disinfectants for hygienic purposes; ] chemical preparations for pharmaceutical purposes, namely, for the treatment of [ genetic, cardiovascular, ] central nervous system, endocrine, [ gastrointestinal, hepatic, biliary, ] immunological, allergic, [ pulmonary, ] dermatological, infectious, inflammatory, [ menopausal, nutritional, metabolic, diabetes, autoimmune, musculoskeletal, connective tissue, ] neurological [ , ophthalmologic, psychiatric, respiratory, urogenital, urological, erectile dysfunction, sexual dysfunction, gynecology, obstetric, pediatric, hematologic, oncological, fungal and viral diseases and disorders; diagnostic preparations for medical use, diagnostic reagents for medicinal use; veterinary preparations, namely, pain relief medication, as well as for the treatment of cardiovascular, central nervous system, gastrointestinal, hepatic, biliary, allergic, dermatological, infectious, inflammatory, nutritional, musculoskeletal, neurological, ophthalmologic, respiratory, urogenital, urological, gynecology, oncological, fungal and viral diseases and disorders ]

Medical services; [ veterinary services; hygienic and beauty care for human beings or animals; ] development and design services in the nature of medical and pharmaceutical consultation relating to diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and medical products

Filing History

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Oct 24, 2025 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Oct 24, 2025 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 20, 2025 APRE
TEAS SECTION 71 & 15 RECEIVED
Jul 2, 2025 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 11, 2024 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 12, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 24, 2019 FICS
FINAL DISPOSITION PROCESSED
Sep 24, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 11, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 11, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 26, 2019 NPUB
PUBLISHED FOR OPPOSITION
Mar 26, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 6, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 14, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 28, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 28, 2019 CRFA
ASSIGNED TO LIE
Jan 18, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 16, 2019 TROA
REFUSAL PROCESSED BY IB
Jan 11, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 27, 2018 RFCS
REFUSAL PROCESSED BY MPU
Dec 27, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 11, 2018 RFCR
NON-FINAL ACTION WRITTEN
Dec 10, 2018 CNRT
APPLICATION FILING RECEIPT MAILED
Nov 27, 2018 MAFR
ASSIGNED TO EXAMINER
Nov 23, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 23, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 22, 2018 REPR